Cortisol Reactivity to Stress Among Youth: Stability over Time and Genetic Variants for Stress Sensitivity

Overview

Journal J Abnorm Psychol

Publisher American Psychological Association

Specialty Psychology

Date 2015 Feb 18

PMID 25688432

Citations 17

Authors

Benjamin L Hankin

Lisa S Badanes

Andrew Smolen

Jami F Young

Affiliations

Soon will be listed here.

Abstract

Stress sensitivity may be one process that can explain why some genetically at-risk individuals are more susceptible to some types of stress-reactive psychopathologies. Dysregulation of the limbic-hypothalamic-pituitary-adrenal (LHPA) axis, including cortisol reactivity to challenge, represents a key aspect of stress sensitivity. However, the degree of stability over time among youth, especially differential stability as a function of particular genetic variants, has not been investigated. A general community sample of children and adolescents (mean age = 11.4; 56% girls) provided a DNA sample and completed 2 separate laboratory stress challenges, across an 18-month follow-up (N = 224 at Time 1; N = 194 at Time 2), with repeated measures of salivary cortisol. Results showed that test-retest stability for several indices of cortisol reactivity across the laboratory challenge visits were significant and of moderate magnitude for the whole sample. Moreover, gene variants of several biologically plausible systems relevant for stress sensitivity (especially 5-HTTLPR and CRHR1) demonstrated differential stability of cortisol reactivity over 18-months, such that carriers of genotypes conferring enhanced environmental susceptibility exhibited greater stability of cortisol levels over time for some LHPA axis indices. Findings suggest that LHPA axis dysregulation may exhibit some trait-like aspects underlying stress sensitivity in youth, especially for those who carry genes related to greater genetic susceptibility to environmental stress.

Citing Articles

The Interaction of Polygenic Susceptibility to Stress and Childhood Adversity Dimensions Predicts Longitudinal Trajectories of Stress-Sensitivity.

Barrantes-Vidal N, Gizdic A, Torrecilla P, Mas-Bermejo P, Sheinbaum T, Papiol S Stress Health. 2024; 40(6):e3499.

PMID: 39540673 PMC: 11636442. DOI: 10.1002/smi.3499.

Effect of yoga in medical students to reduce the level of depression, anxiety, and stress: pilot study (Goodbye Stress with Yoga GSY).

Chauhan S, Babu A, Galgalo D, Melczer C, Premusz V, Karsai I BMC Complement Med Ther. 2024; 24(1):203.

PMID: 38790041 PMC: 11127401. DOI: 10.1186/s12906-024-04496-0.

Repeated Sevoflurane Exposure in Neonatal Rats Enhances the Sensitivity to Pain and Traumatic Stress Later in Juvenile Life.

Chen B, Jiang L, Zhou W, Shang Y, Li F, Liu B J Pain Res. 2022; 15:3171-3178.

PMID: 36258761 PMC: 9572549. DOI: 10.2147/JPR.S365253.

Usability, Feasibility, and Effect of a Biocueing Intervention in Addition to a Moderated Digital Social Therapy-Platform in Young People With Emerging Mental Health Problems: A Mixed-Method Approach.

van Doorn M, Nijhuis L, Monsanto A, van Amelsvoort T, Popma A, Jaspers M Front Psychiatry. 2022; 13:871813.

PMID: 35693972 PMC: 9174529. DOI: 10.3389/fpsyt.2022.871813.

The "vestibular neuromatrix": A proposed, expanded vestibular network from graph theory in post-concussive vestibular dysfunction.

Smith J, Trofimova A, Ahluwalia V, Casado Garrido J, Hurtado J, Frank R Hum Brain Mapp. 2021; 43(5):1501-1518.

PMID: 34862683 PMC: 8886666. DOI: 10.1002/hbm.25737.

References

Vreeburg S, Zitman F, van Pelt J, DeRijk R, Verhagen J, van Dyck R . Salivary cortisol levels in persons with and without different anxiety disorders. Psychosom Med. 2010; 72(4):340-7. DOI: 10.1097/PSY.0b013e3181d2f0c8. View

Moffitt T, Caspi A, Rutter M . Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry. 2005; 62(5):473-81. DOI: 10.1001/archpsyc.62.5.473. View

Koenen K, Amstadter A, Nugent N . Gene-environment interaction in posttraumatic stress disorder: an update. J Trauma Stress. 2009; 22(5):416-26. PMC: 2889033. DOI: 10.1002/jts.20435. View

Oppenheimer C, Hankin B, Young J, Smolen A . Youth genetic vulnerability to maternal depressive symptoms: 5-HTTLPR as moderator of intergenerational transmission effects in a multiwave prospective study. Depress Anxiety. 2013; 30(3):190-6. PMC: 3717260. DOI: 10.1002/da.22056. View

Stroud L, Salovey P, Epel E . Sex differences in stress responses: social rejection versus achievement stress. Biol Psychiatry. 2002; 52(4):318-27. DOI: 10.1016/s0006-3223(02)01333-1. View

Petersen A, Crockett L, Richards M, Boxer A . A self-report measure of pubertal status: Reliability, validity, and initial norms. J Youth Adolesc. 2013; 17(2):117-33. DOI: 10.1007/BF01537962. View

Miller R, Wankerl M, Stalder T, Kirschbaum C, Alexander N . The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and cortisol stress reactivity: a meta-analysis. Mol Psychiatry. 2012; 18(9):1018-24. DOI: 10.1038/mp.2012.124. View

Lupien S, McEwen B, Gunnar M, Heim C . Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci. 2009; 10(6):434-45. DOI: 10.1038/nrn2639. View

Hankin B, Nederhof E, Oppenheimer C, Jenness J, Young J, Abela J . Differential susceptibility in youth: evidence that 5-HTTLPR x positive parenting is associated with positive affect 'for better and worse'. Transl Psychiatry. 2012; 1:e44. PMC: 3309487. DOI: 10.1038/tp.2011.44. View

10.

Pruessner J, Wolf O, Hellhammer D, Buske-Kirschbaum A, von Auer K, Jobst S . Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 1997; 61(26):2539-49. DOI: 10.1016/s0024-3205(97)01008-4. View

11.

Haberstick B, Smolen A . Genotyping of three single nucleotide polymorphisms following whole genome preamplification of DNA collected from buccal cells. Behav Genet. 2004; 34(5):541-7. DOI: 10.1023/B:BEGE.0000038492.50446.25. View

12.

Hariri A, Drabant E, Munoz K, Kolachana B, Mattay V, Egan M . A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry. 2005; 62(2):146-52. DOI: 10.1001/archpsyc.62.2.146. View

13.

Walder D, Trotman H, Cubells J, Brasfield J, Tang Y, Walker E . Catechol-O-methyltransferase modulation of cortisol secretion in psychiatrically at-risk and healthy adolescents. Psychiatr Genet. 2010; 20(4):166-70. PMC: 3522124. DOI: 10.1097/YPG.0b013e32833a1ff3. View

14.

Dietz D, Dietz K, Moore S, Ouimet C, Kabbaj M . Repeated social defeat stress-induced sensitization to the locomotor activating effects of d-amphetamine: role of individual differences. Psychopharmacology (Berl). 2008; 198(1):51-62. DOI: 10.1007/s00213-008-1078-y. View

15.

Zubieta J, Heitzeg M, Smith Y, Bueller J, Xu K, Xu Y . COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science. 2003; 299(5610):1240-3. DOI: 10.1126/science.1078546. View

16.

Susman E, Dockray S, Granger D, Blades K, Randazzo W, Heaton J . Cortisol and alpha amylase reactivity and timing of puberty: vulnerabilities for antisocial behaviour in young adolescents. Psychoneuroendocrinology. 2009; 35(4):557-69. PMC: 2843813. DOI: 10.1016/j.psyneuen.2009.09.004. View

17.

Gotlib I, Joormann J, Minor K, Hallmayer J . HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression. Biol Psychiatry. 2007; 63(9):847-51. PMC: 2373542. DOI: 10.1016/j.biopsych.2007.10.008. View

18.

Camara E, Kramer U, Cunillera T, Marco-Pallares J, Cucurell D, Nager W . The effects of COMT (Val108/158Met) and DRD4 (SNP -521) dopamine genotypes on brain activations related to valence and magnitude of rewards. Cereb Cortex. 2009; 20(8):1985-96. DOI: 10.1093/cercor/bhp263. View

19.

Walker E, Sabuwalla Z, Huot R . Pubertal neuromaturation, stress sensitivity, and psychopathology. Dev Psychopathol. 2005; 16(4):807-24. DOI: 10.1017/s0954579404040027. View

20.

Mehta D, Binder E . Gene × environment vulnerability factors for PTSD: the HPA-axis. Neuropharmacology. 2011; 62(2):654-62. DOI: 10.1016/j.neuropharm.2011.03.009. View